Toggle navigation
TWunroll
TWunroll
faq
Contact US
Stephen V Liu
StephenVLiu
#OncoAlert Results from the phase III TAHOE trial now available @JTOonline - compared 2L rovalpituzumab-teserine (Rova-T) versus topotecan in DLL3-high #SCLC. Stopped early for futility, not meeting its OS endpoint.
Read more
#OncoAlert Retrospective report @JTOonline on outcomes with chemoradiation plus durvalumab (PACIFIC) in patients with #EGFR mutant NSCLC. #LCSM https://www.jto.org/article/S1556-0864(21)01702-0/fulltext Cohort of 37 patients with #EGFR muta
Read more
#WCLC20 Passionate plea to clinical investigators designing clinical trials by @jillfeldman4 at the @IASLC plenary. Eloquent articulation at some of the fundamental flaws in our research infrastructure. This is a
Read more
#WCLC20 The plenary presentation by @GoldmanLisa on patient-directed research and lessons in partnership is a can't miss and gives important insight into the evolution of clinical research #LCSM @IASLC @OncoAlert
Read more
#OncoAlert Available @NEJM, results from the phase III CROWN trial of lorlatinib versus crizotinib as first line treatment for #ALK NSCLC. Initially presented at virtual #ESMO20, lorlatinib had a significantly
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our
Cookie Policy
to improve your experience.
I agree